|
1. |
Subspecialization—the Dilemma of Internal Medicine |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 385-386
Bent Harvald,
Preview
|
PDF (133KB)
|
|
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02784.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
2. |
Tumour Necrosis Factor—an Overview |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 387-394
C. P. J. MAURY,
Preview
|
PDF (568KB)
|
|
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02785.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
3. |
A Study of the Association between the Prolongation of the QT Interval in the Resting ECG and Myocardial Infarction |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 395-400
PATRICIA M. ROBERTS,
J. GEORGE FODOR,
GÖSTA TIBBLIN,
LARS WILHELMSEN,
Preview
|
PDF (405KB)
|
|
摘要:
ABSTRACTThe relationship between the incidence of myocardial infarction in the 10 year follow‐up period and the length of the QT interval and its two components (the time elapsing between the Q wave and the beginning of the T wave, and the duration of the T wave) was investigated in a study of the records of a group of men drawn from a random sample of all 55‐year‐old men living in Göteborg, Sweden. A significant association was found between the incidence of myocardial infarction and the first component but not with the second component or the QT interval itself. The two components were found to be independent and thus to have the potential to act as confounding factors if the QT interval is examined alone. Further, our results suggest that correcting the QT interval for heart rate needs careful reasse
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02786.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
4. |
Platelet Number and Volume during Myocardial Infarction in Relation to Infarct Size |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 401-405
TORBEN GLUD,
ERIK BERG SCHMIDT,
STEEN DALBY KRISTENSEN,
TERKEL ARNFRED,
Preview
|
PDF (304KB)
|
|
摘要:
ABSTRACTPlatelet number and mean platelet volume (MPV) were measured in 100 patients with acute chest pain, 41 with acute myocardial infarction (AMI), 33 with angina pectoris (AP) and 26 with non‐coronary event (NCE), and compared with 21 controls. We found no significant difference in platelet count on admission in the patient groups, but it was lower compared with controls. There were no significant differences in MPV between the patient groups nor between patients and controls. Thirty patients with AMI were followed for 10 days and showed an initial 12% fall in platelet count followed by a 36% increase. Initially there was an increase in MPV (2%) followed by a fall (8%). The fall in platelet count and increase in MPV correlated with infarct size (maximum activity of lactate dehydrogenase (LDH)) and might reflect consumption of platelets. The precise role of platelets in the process of infarction is still unknow
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02787.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
5. |
Warfarin and Uric Acid after Myocardial Infarction |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 407-410
PÅL SMITH,
HARALD ARNESEN,
Preview
|
PDF (209KB)
|
|
摘要:
ABSTRACTIn order to assess the influence of warfarin on serum urate concentration, changes in serum urate were studied in 50 patients after myocardial infarction. The patients studied were part of a prospective, randomized placebo‐controlled study of warfarin after myocardial infarction. Twenty‐three of the patients were treated with warfarin and 27 received placebo. The mean uric acid level fell in both groups during an average of 10 months (range 6‐20 months), the reduction being of the same order of magnitude in either group. This implies that warfarin, in contrast to some other oral anticoagulants, does not exert any uric acid lowering e
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02788.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
6. |
Variability of Blood Pressure in Ambulatory Hypertensive Patients: Effects of Verapamil on Twice and Thrice Daily Dose Regimens |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 411-418
ULF FAIRE,
LENNART FORSLUND,
ANDERS ODÉN,
Preview
|
PDF (424KB)
|
|
摘要:
ABSTRACTThe antihypertensive effects of verapamil over 24 hours were assessed on twice and thrice daily dose regimens on 12 patients (25–65 years of age; mean age 50) with essential hypertension (WHO stages I–II) in a randomised, double‐blind, cross‐over trial. After a dose titration period starting with either verapamil 80 mg tid or 120 mg bid the patients kept their maintenance dose (240, 360 or 480 mg daily) for 4 weeks before crossing over to the other administration schedule. Repeated ambulatory blood pressure (BP) curves were recorded in 10 patients with a non‐invasive portable device (Pressurometer III, Del Mar Avionics). The BP reductions (causal BP values) obtained by 2‐ and 3‐dose regimens were of similar magnitude (from 170±19/105±8 on placebo to 140±17/87±7 and to 146±14/88±8 by 2‐ and 3‐dose respectively). Analyses of BP curves revealed close similarity in profiles on the two dose regimens, although DBP was significantly (p<0.05) lower by 3‐dose as compared to 2‐dose regimen during the period 0.00–2.59 a.m. Long‐term (circadian rhythm) and short‐term variability did not differ between the regimens. Despite the slight difference in DBP curves after midnight, the overall impression is that verapamil given both twice and thrice daily provides adequa
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02789.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
7. |
Low‐dose Antihypertensive Treatment with a Thiazide Diuretic Is Not Diabetogenic |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 419-424
GÖRAN BERGLUND,
OVE ANDERSSON,
BENGT WIDGREN,
Preview
|
PDF (370KB)
|
|
摘要:
ABSTRACTBlood pressure (BP) and metabolic variables were determined initially and after 1, 2, 4, 6 and 10 years' treatment in two groups of hypertensive men (n= 53 each) randomized to bendroflumethiazide 2.5–5 mg/day or propranolol 160–320 mg daily. There was no significant differences in BP or metabolic variables between the two groups at entry. BP was reduced to the same degree by both treatments. Five men in the propranolol group and one man in the thiazide group developed clinically overt diabetes during follow‐up. Fasting blood sugar increased slightly but significantly though equally in both groups. Oral glucose tolerance was initially impaired to the same degree in both groups but improved significantly during treatment with both drugs. Fasting insulin increased slightly but to the same degree. While serum potassium decreased significantly in the thiazide group, the total body potassium was unchanged in this group. In the propranolol group, serum potassium rose, while total body potassium decreased significantly. Serum urate increased in both groups, though slightly more during thiazide treatment. One case of gout was found in each group. There was no difference in serum lipids between the two groups. The findings in this long‐term trial indicate that in middle‐aged men with mild to moderate hypertension a low‐dose thiazide diuretic like bendroflumethiazide is as effective and safe an antihypertensive agent as the β‐blocker propranolol is and that it does not induce diabetes. The total clinical picture favors the retention of thiazide diuretics as a first choice drug i
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02790.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
8. |
Venous Thromboembolism after Cerebral Infarction and the Prophylactic Effect of Dextran 40 |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 425-429
GÖRAN MELLBRING,
TAGE STRAND,
STURE ERIKSSON,
Preview
|
PDF (340KB)
|
|
摘要:
ABSTRACTIn a prospective study of the incidence of deep vein thrombosis (DVT) after stroke, and the prophylactic effect of dextran, 50 patients, admitted with a diagnosis of cerebral infarction with paresis of the lower extremity within the first 48 hours, were randomly allocated to treatment or non‐treatment groups. The treatment group received 500 ml of dextran 40 on admission and on days 1 and 2, and 250 ml on days 4 and 6. Venesection was performed on admission and if necessary on day 1. The control group received no dextran or venesection. DVT was diagnosed with the125I‐fibrinogen test during the first ten days. The incidence of DVT was 54% in the treatment group and 50% in the control group. There were no statistically significant differences between the groups regarding number of DVTs needing treatment, number of positive scanning points or number of days for scan to become positive. Lethal pulmonary emboli occurred in one treated and in three control patients, respectively. Age and progress of neurologic symptoms predisposed for the development of DVT. The high incidence of DVT in stroke patients indicates the need for prophylactic routi
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02791.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
9. |
Plasma Concentrations of Complement Split Product C3d and Immune Complexes after Procainamide Induced Production of Antinuclear Antibodies |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 431-435
I. BRANDSLUND,
H. H. W. IBSEN,
N. A. KLITGAARD,
S.‐E. SVEHAG,
E. SIMONSEN,
H. DIEDERICHSEN,
Preview
|
PDF (316KB)
|
|
摘要:
ABSTRACTSeventeen patients treated with procainamide for cardiac ventricular arrhythmias were followed for up to 40 weeks. Immunological data as a clue to developing the systemic lupus erythematosus (SLE)‐like syndrome was emphasized. Ten patients developed antinuclear antibodies (IgG or IgM), but no increase in the plasma concentration of the complement split product C3d or immune complexes, measured by two different methods, was demonstrated. This finding is in contrast to the high levels of both C3d and immune complexes in SLE. The discrepancy may be caused by a lack of immune complex mediated complement activation by the procainamide induced antibodies, or may be due to a difference in severity of disease. The acetylator phenotype of the patients was determined but due to the low frequency of fast acetylators no comparison of the immunological response of the two phenotypes could be don
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02792.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
10. |
Epidemiology of Diabetes Mellitus in Sweden |
|
Acta Medica Scandinavica,
Volume 220,
Issue 5,
1986,
Page 437-445
J. ÖSTMAN,
H. ARNQVIST,
G. BLOHMÉ,
F. LITHNER,
B. LITTORIN,
L. NYSTRÖM,
A. SANDSTRÖM,
B. SCHERSTÉN,
S. WALL,
L. WIBELL,
Preview
|
PDF (495KB)
|
|
摘要:
ABSTRACTAll newly diagnosed cases of diabetes mellitus aged 15–34 years in Sweden, where the population in this age interval is about 2.3 million, were registered on standardized forms. During 1983, the first year of the study, there were 311 males and 161 females, excluding 280 with gestational diabetes. The annual incidence of diabetes was 26.2 per 100000 in males and 14.2 in females. The respective figures for type I were 18.5 and 10.1, and for type II 5.7 and 2.9. The incidence of type I diabetes was similar for the four age groups (15–19, 20–24, 25–29, 30–34 years), while for type II it was highest in the oldest group. Types I and II, but not the sexes, differed as regards the cumulative distribution curves of the maximum blood glucose concentration during the first two weeks after diagnosis. The present incidence of diabetes in Sweden is higher, particularly in males than the rates for similar age groups in Oslo (1925–64) and Denmar
ISSN:0001-6101
DOI:10.1111/j.0954-6820.1986.tb02793.x
出版商:Blackwell Publishing Ltd
年代:1986
数据来源: WILEY
|
|